Patents not ‘limiting factor’ for vaccine production: BioNTech
German firm BioNTech said Thursday that patent protection for COVID-19 vaccines is not holding back production or supply of the jabs that it developed with Pfizer.
- Next story The Division getting a standalone free-to-play game called Heartland
- Previous story Mayo Clinic Minute: Lifestyle changes to manage menopause symptoms
Explore more
- Business Updates: Fervor Over Coinbase I.P.O. Spreads
Coinbase, a company that allows people and companies to buy and sell... - Jury Set to Resume Deliberations in Chauvin Trial
The jurors, who began deliberating for four hours on Monday night, must... - How to manage anxiety about returning to the office
With COVID-19 vaccines becoming more widely available and mask mandates lifting, a... - When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins
Untreated hepatitis C can lead to serious and life-threatening health problems like... - Homes That Sold for Around $1.5 Million
Recent residential sales in New York City and the region. - The best 5G phones to buy in 2021
5G coverage is constantly growing. If you’re near a major city, maybe... - Victims Identified in San Jose Rail Yard Shooting That Killed 9
The victims ranged in age from 29 to 63. Many were fellow... - Bangladesh shuts down offices, transport amid pandemic surge
Bangladesh authorities on Monday ordered an eight-day closure of all offices and... - Pivotal results from clinical trial for the chronic condition atopic dermatitis
The findings of a clinical trial by Trinity College Dublin researchers of... - Kim Kardashian West fangirls over ‘Bridgerton’s’ Featheringtons being inspired by her family
Kim Kardashian West may be a tad bit late to the “Bridgerton”...